Glass Jacobson Investment Advisors LLC Viking Therapeutics, Inc. Transaction History
Glass Jacobson Investment Advisors LLC
- $275 Billion
- Q2 2024
A detailed history of Glass Jacobson Investment Advisors LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Glass Jacobson Investment Advisors LLC holds 375 shares of VKTX stock, worth $24,041. This represents 0.01% of its overall portfolio holdings.
Number of Shares
375
Previous 375
-0.0%
Holding current value
$24,041
Previous $30.8 Million
35.35%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
443Shares Held
63.4MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$647 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$386 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$328 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$144 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$119 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.92B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...